nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—atherosclerosis	0.535	1	CbGaD
Gadobenate Dimeglumine—ALB—Rosuvastatin—atherosclerosis	0.183	1	CbGbCtD
Gadobenate Dimeglumine—Myalgia—Rosuvastatin—atherosclerosis	0.000494	0.00276	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Rosuvastatin—atherosclerosis	0.000494	0.00276	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Simvastatin—atherosclerosis	0.00049	0.00274	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Niacin—atherosclerosis	0.000486	0.00272	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Ezetimibe—atherosclerosis	0.000485	0.00272	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Niacin—atherosclerosis	0.000482	0.0027	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Ezetimibe—atherosclerosis	0.000482	0.0027	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Ezetimibe—atherosclerosis	0.000482	0.0027	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Lovastatin—atherosclerosis	0.000481	0.00269	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Pravastatin—atherosclerosis	0.000479	0.00268	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Niacin—atherosclerosis	0.000478	0.00267	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Rosuvastatin—atherosclerosis	0.000477	0.00267	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Lovastatin—atherosclerosis	0.000475	0.00266	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Pravastatin—atherosclerosis	0.000475	0.00266	CcSEcCtD
Gadobenate Dimeglumine—Chills—Simvastatin—atherosclerosis	0.000474	0.00265	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Lovastatin—atherosclerosis	0.000472	0.00264	CcSEcCtD
Gadobenate Dimeglumine—Infection—Rosuvastatin—atherosclerosis	0.00047	0.00263	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Niacin—atherosclerosis	0.000467	0.00262	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Ezetimibe—atherosclerosis	0.000466	0.00261	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000464	0.0026	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Ezetimibe—atherosclerosis	0.000463	0.00259	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Simvastatin—atherosclerosis	0.000463	0.00259	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Lovastatin—atherosclerosis	0.00046	0.00258	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Pravastatin—atherosclerosis	0.00046	0.00257	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Simvastatin—atherosclerosis	0.00046	0.00257	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000456	0.00255	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Niacin—atherosclerosis	0.000453	0.00254	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Niacin—atherosclerosis	0.000452	0.00253	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Simvastatin—atherosclerosis	0.00045	0.00252	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Niacin—atherosclerosis	0.00045	0.00252	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Lovastatin—atherosclerosis	0.000449	0.00251	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000447	0.0025	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Ezetimibe—atherosclerosis	0.000445	0.00249	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Pravastatin—atherosclerosis	0.000445	0.00249	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Lovastatin—atherosclerosis	0.000443	0.00248	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Pravastatin—atherosclerosis	0.000443	0.00248	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Pravastatin—atherosclerosis	0.000443	0.00248	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Simvastatin—atherosclerosis	0.000442	0.00247	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Ezetimibe—atherosclerosis	0.00044	0.00247	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Niacin—atherosclerosis	0.00044	0.00246	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Lovastatin—atherosclerosis	0.00044	0.00246	CcSEcCtD
Gadobenate Dimeglumine—Chills—Niacin—atherosclerosis	0.000435	0.00243	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Ezetimibe—atherosclerosis	0.000435	0.00243	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Niacin—atherosclerosis	0.000433	0.00242	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000431	0.00241	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Simvastatin—atherosclerosis	0.000431	0.00241	CcSEcCtD
Gadobenate Dimeglumine—Chills—Pravastatin—atherosclerosis	0.000428	0.0024	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000426	0.00239	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Pravastatin—atherosclerosis	0.000426	0.00239	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Ezetimibe—atherosclerosis	0.000426	0.00238	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000425	0.00238	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Simvastatin—atherosclerosis	0.000425	0.00238	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Niacin—atherosclerosis	0.000422	0.00236	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Niacin—atherosclerosis	0.000422	0.00236	CcSEcCtD
Gadobenate Dimeglumine—Cough—Ezetimibe—atherosclerosis	0.000421	0.00235	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Simvastatin—atherosclerosis	0.00042	0.00235	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Lovastatin—atherosclerosis	0.000418	0.00234	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Lovastatin—atherosclerosis	0.000418	0.00234	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Lovastatin—atherosclerosis	0.000418	0.00234	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Lovastatin—atherosclerosis	0.000417	0.00233	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000417	0.00233	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Ezetimibe—atherosclerosis	0.000416	0.00233	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Simvastatin—atherosclerosis	0.000414	0.00232	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Lovastatin—atherosclerosis	0.000413	0.00231	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Simvastatin—atherosclerosis	0.000411	0.0023	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Ezetimibe—atherosclerosis	0.00041	0.0023	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Ezetimibe—atherosclerosis	0.00041	0.0023	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Ezetimibe—atherosclerosis	0.00041	0.0023	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Lovastatin—atherosclerosis	0.000409	0.00229	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000407	0.00228	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Pravastatin—atherosclerosis	0.000407	0.00228	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—SOD1—atherosclerosis	0.000406	0.00393	CbGpPWpGaD
Gadobenate Dimeglumine—Muscle spasms—Niacin—atherosclerosis	0.000406	0.00227	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Ezetimibe—atherosclerosis	0.000405	0.00227	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—PLAT—atherosclerosis	0.000405	0.00392	CbGpPWpGaD
Gadobenate Dimeglumine—Constipation—Rosuvastatin—atherosclerosis	0.000405	0.00227	CcSEcCtD
Gadobenate Dimeglumine—Pain—Rosuvastatin—atherosclerosis	0.000405	0.00227	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Lovastatin—atherosclerosis	0.000404	0.00226	CcSEcCtD
Gadobenate Dimeglumine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—atherosclerosis	0.000404	0.00391	CbGpPWpGaD
Gadobenate Dimeglumine—Dry mouth—Ezetimibe—atherosclerosis	0.000401	0.00225	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000401	0.00224	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Pravastatin—atherosclerosis	0.0004	0.00224	CcSEcCtD
Gadobenate Dimeglumine—Infection—Lovastatin—atherosclerosis	0.000398	0.00223	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Ezetimibe—atherosclerosis	0.000397	0.00222	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000393	0.0022	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Simvastatin—atherosclerosis	0.000391	0.00219	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Simvastatin—atherosclerosis	0.000391	0.00219	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Simvastatin—atherosclerosis	0.000391	0.00219	CcSEcCtD
Gadobenate Dimeglumine—Infection—Ezetimibe—atherosclerosis	0.000391	0.00219	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00039	0.00218	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Simvastatin—atherosclerosis	0.00039	0.00218	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Pravastatin—atherosclerosis	0.000389	0.00218	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—VWF—atherosclerosis	0.000389	0.00376	CbGpPWpGaD
Gadobenate Dimeglumine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000387	0.00217	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Simvastatin—atherosclerosis	0.000387	0.00216	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000386	0.00216	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Niacin—atherosclerosis	0.000386	0.00216	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000386	0.00216	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Pravastatin—atherosclerosis	0.000384	0.00215	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Ezetimibe—atherosclerosis	0.000382	0.00214	CcSEcCtD
Gadobenate Dimeglumine—ALB—Lipid and lipoprotein metabolism—APOB—atherosclerosis	0.00038	0.00368	CbGpPWpGaD
Gadobenate Dimeglumine—Angioedema—Pravastatin—atherosclerosis	0.00038	0.00213	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Niacin—atherosclerosis	0.000378	0.00212	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Simvastatin—atherosclerosis	0.000378	0.00212	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Niacin—atherosclerosis	0.000378	0.00211	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—MPO—atherosclerosis	0.000376	0.00364	CbGpPWpGaD
Gadobenate Dimeglumine—Urticaria—Rosuvastatin—atherosclerosis	0.000376	0.0021	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000375	0.0021	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Pravastatin—atherosclerosis	0.000375	0.0021	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—APOB—atherosclerosis	0.000374	0.00362	CbGpPWpGaD
Gadobenate Dimeglumine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000374	0.00209	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—LDLR—atherosclerosis	0.000374	0.00362	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—ESAM—atherosclerosis	0.000374	0.00361	CbGpPWpGaD
Gadobenate Dimeglumine—Palpitations—Niacin—atherosclerosis	0.000373	0.00209	CcSEcCtD
Gadobenate Dimeglumine—Infection—Simvastatin—atherosclerosis	0.000373	0.00209	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Pravastatin—atherosclerosis	0.000372	0.00208	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Niacin—atherosclerosis	0.000371	0.00208	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—ABCA1—atherosclerosis	0.000371	0.00358	CbGpPWpGaD
Gadobenate Dimeglumine—Cough—Niacin—atherosclerosis	0.000368	0.00206	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—SOD2—atherosclerosis	0.000365	0.00353	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—CCL5—atherosclerosis	0.000365	0.00353	CbGpPWpGaD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000365	0.00205	CcSEcCtD
Gadobenate Dimeglumine—ALB—Lipid and lipoprotein metabolism—LPL—atherosclerosis	0.000363	0.00351	CbGpPWpGaD
Gadobenate Dimeglumine—Cough—Pravastatin—atherosclerosis	0.000363	0.00203	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—F7—atherosclerosis	0.000361	0.00349	CbGpPWpGaD
Gadobenate Dimeglumine—Paraesthesia—Lovastatin—atherosclerosis	0.00036	0.00202	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Niacin—atherosclerosis	0.000359	0.00201	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Niacin—atherosclerosis	0.000359	0.00201	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Pravastatin—atherosclerosis	0.000359	0.00201	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000358	0.00201	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Lovastatin—atherosclerosis	0.000358	0.002	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000357	0.002	CcSEcCtD
Gadobenate Dimeglumine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—atherosclerosis	0.000357	0.00345	CbGpPWpGaD
Gadobenate Dimeglumine—Myalgia—Pravastatin—atherosclerosis	0.000354	0.00198	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Pravastatin—atherosclerosis	0.000354	0.00198	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Pravastatin—atherosclerosis	0.000354	0.00198	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Ezetimibe—atherosclerosis	0.000353	0.00198	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Lovastatin—atherosclerosis	0.000353	0.00198	CcSEcCtD
Gadobenate Dimeglumine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—atherosclerosis	0.000353	0.00341	CbGpPWpGaD
Gadobenate Dimeglumine—Anxiety—Pravastatin—atherosclerosis	0.000353	0.00197	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Niacin—atherosclerosis	0.000351	0.00197	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Ezetimibe—atherosclerosis	0.000351	0.00196	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—SCARB1—atherosclerosis	0.00035	0.00338	CbGpPWpGaD
Gadobenate Dimeglumine—Discomfort—Pravastatin—atherosclerosis	0.00035	0.00196	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000349	0.00195	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Ezetimibe—atherosclerosis	0.000346	0.00194	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Lovastatin—atherosclerosis	0.000346	0.00194	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—PLG—atherosclerosis	0.000344	0.00333	CbGpPWpGaD
Gadobenate Dimeglumine—Anaphylactic shock—Niacin—atherosclerosis	0.000344	0.00193	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Lovastatin—atherosclerosis	0.000343	0.00192	CcSEcCtD
Gadobenate Dimeglumine—Pain—Lovastatin—atherosclerosis	0.000343	0.00192	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Pravastatin—atherosclerosis	0.000342	0.00191	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000342	0.00191	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00034	0.0019	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Rosuvastatin—atherosclerosis	0.00034	0.0019	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000339	0.0019	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Ezetimibe—atherosclerosis	0.000339	0.0019	CcSEcCtD
Gadobenate Dimeglumine—Shock—Niacin—atherosclerosis	0.000339	0.0019	CcSEcCtD
Gadobenate Dimeglumine—Infection—Pravastatin—atherosclerosis	0.000337	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Simvastatin—atherosclerosis	0.000337	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Ezetimibe—atherosclerosis	0.000336	0.00188	CcSEcCtD
Gadobenate Dimeglumine—Pain—Ezetimibe—atherosclerosis	0.000336	0.00188	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Niacin—atherosclerosis	0.000336	0.00188	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Rosuvastatin—atherosclerosis	0.000335	0.00187	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Niacin—atherosclerosis	0.000335	0.00187	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Simvastatin—atherosclerosis	0.000334	0.00187	CcSEcCtD
Gadobenate Dimeglumine—ALB—FOXA2 and FOXA3 transcription factor networks—APOA1—atherosclerosis	0.000333	0.00322	CbGpPWpGaD
Gadobenate Dimeglumine—Hyperhidrosis—Niacin—atherosclerosis	0.000333	0.00186	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Lovastatin—atherosclerosis	0.00033	0.00185	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—SOD1—atherosclerosis	0.00033	0.00319	CbGpPWpGaD
Gadobenate Dimeglumine—Dyspepsia—Simvastatin—atherosclerosis	0.00033	0.00185	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000328	0.00184	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000328	0.00184	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000324	0.00181	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000324	0.00181	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000324	0.00181	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Simvastatin—atherosclerosis	0.000323	0.00181	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Niacin—atherosclerosis	0.000322	0.0018	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—PLAT—atherosclerosis	0.000322	0.00311	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—MTHFR—atherosclerosis	0.000322	0.00311	CbGpPWpGaD
Gadobenate Dimeglumine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000322	0.0018	CcSEcCtD
Gadobenate Dimeglumine—Pain—Simvastatin—atherosclerosis	0.000321	0.0018	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Simvastatin—atherosclerosis	0.000321	0.0018	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Lovastatin—atherosclerosis	0.000319	0.00178	CcSEcCtD
Gadobenate Dimeglumine—ALB—FOXA2 and FOXA3 transcription factor networks—F2—atherosclerosis	0.000318	0.00307	CbGpPWpGaD
Gadobenate Dimeglumine—Body temperature increased—Lovastatin—atherosclerosis	0.000317	0.00177	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Lovastatin—atherosclerosis	0.000317	0.00177	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000314	0.00176	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Rosuvastatin—atherosclerosis	0.000313	0.00175	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Ezetimibe—atherosclerosis	0.000312	0.00175	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Ezetimibe—atherosclerosis	0.000311	0.00174	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Ezetimibe—atherosclerosis	0.000311	0.00174	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Niacin—atherosclerosis	0.000309	0.00173	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Simvastatin—atherosclerosis	0.000309	0.00173	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000309	0.00173	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Niacin—atherosclerosis	0.000307	0.00172	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000307	0.00172	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Niacin—atherosclerosis	0.000306	0.00171	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—CRP—atherosclerosis	0.000306	0.00296	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—KNG1—atherosclerosis	0.000305	0.00295	CbGpPWpGaD
Gadobenate Dimeglumine—Paraesthesia—Pravastatin—atherosclerosis	0.000305	0.0017	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—APOB—atherosclerosis	0.000305	0.00294	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Lipid and lipoprotein metabolism—APOE—atherosclerosis	0.000304	0.00294	CbGpPWpGaD
Gadobenate Dimeglumine—Dyspepsia—Niacin—atherosclerosis	0.000303	0.0017	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Pravastatin—atherosclerosis	0.000302	0.00169	CcSEcCtD
Gadobenate Dimeglumine—ALB—Lipid and lipoprotein metabolism—CAV1—atherosclerosis	0.000302	0.00292	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Lipid and lipoprotein metabolism—APOA1—atherosclerosis	0.000301	0.00291	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—APOE—atherosclerosis	0.0003	0.0029	CbGpPWpGaD
Gadobenate Dimeglumine—Dyspepsia—Pravastatin—atherosclerosis	0.000299	0.00167	CcSEcCtD
Gadobenate Dimeglumine—Rash—Rosuvastatin—atherosclerosis	0.000298	0.00167	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Rosuvastatin—atherosclerosis	0.000298	0.00167	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Simvastatin—atherosclerosis	0.000298	0.00167	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000297	0.00166	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—SOD2—atherosclerosis	0.000297	0.00288	CbGpPWpGaD
Gadobenate Dimeglumine—Abdominal pain—Simvastatin—atherosclerosis	0.000297	0.00166	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Simvastatin—atherosclerosis	0.000297	0.00166	CcSEcCtD
Gadobenate Dimeglumine—Headache—Rosuvastatin—atherosclerosis	0.000296	0.00166	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—APOA1—atherosclerosis	0.000296	0.00286	CbGpPWpGaD
Gadobenate Dimeglumine—Hypersensitivity—Lovastatin—atherosclerosis	0.000295	0.00165	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—PLG—atherosclerosis	0.000295	0.00286	CbGpPWpGaD
Gadobenate Dimeglumine—Pain—Niacin—atherosclerosis	0.000295	0.00165	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—ABCA1—atherosclerosis	0.000294	0.00285	CbGpPWpGaD
Gadobenate Dimeglumine—Fatigue—Pravastatin—atherosclerosis	0.000292	0.00164	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—atherosclerosis	0.00029	0.00281	CbGpPWpGaD
Gadobenate Dimeglumine—Pain—Pravastatin—atherosclerosis	0.00029	0.00162	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Pravastatin—atherosclerosis	0.00029	0.00162	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00029	0.00162	CcSEcCtD
Gadobenate Dimeglumine—ALB—FOXA2 and FOXA3 transcription factor networks—INS—atherosclerosis	0.000288	0.00279	CbGpPWpGaD
Gadobenate Dimeglumine—Asthenia—Lovastatin—atherosclerosis	0.000288	0.00161	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Lovastatin—atherosclerosis	0.000284	0.00159	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—GPX1—atherosclerosis	0.000284	0.00274	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—SOD1—atherosclerosis	0.000283	0.00274	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—F2—atherosclerosis	0.000282	0.00273	CbGpPWpGaD
Gadobenate Dimeglumine—Asthenia—Ezetimibe—atherosclerosis	0.000282	0.00158	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Niacin—atherosclerosis	0.000282	0.00158	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—ICAM1—atherosclerosis	0.000281	0.00272	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—PLG—atherosclerosis	0.000281	0.00272	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Rosuvastatin—atherosclerosis	0.000281	0.00157	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Pravastatin—atherosclerosis	0.000279	0.00156	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Ezetimibe—atherosclerosis	0.000278	0.00156	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000277	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Simvastatin—atherosclerosis	0.000276	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Lovastatin—atherosclerosis	0.000274	0.00154	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—PLG—atherosclerosis	0.000274	0.00265	CbGpPWpGaD
Gadobenate Dimeglumine—Urticaria—Niacin—atherosclerosis	0.000274	0.00153	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Niacin—atherosclerosis	0.000272	0.00152	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Niacin—atherosclerosis	0.000272	0.00152	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—atherosclerosis	0.00027	0.00261	CbGpPWpGaD
Gadobenate Dimeglumine—Urticaria—Pravastatin—atherosclerosis	0.000269	0.00151	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Simvastatin—atherosclerosis	0.000269	0.00151	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Ezetimibe—atherosclerosis	0.000269	0.00151	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—IGF2—atherosclerosis	0.000269	0.0026	CbGpPWpGaD
Gadobenate Dimeglumine—Body temperature increased—Pravastatin—atherosclerosis	0.000268	0.0015	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Pravastatin—atherosclerosis	0.000268	0.0015	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Simvastatin—atherosclerosis	0.000265	0.00149	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Lovastatin—atherosclerosis	0.000265	0.00148	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—SOD1—atherosclerosis	0.000262	0.00254	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—MTHFR—atherosclerosis	0.000262	0.00253	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Ezetimibe—atherosclerosis	0.00026	0.00146	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Simvastatin—atherosclerosis	0.000257	0.00144	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—atherosclerosis	0.000256	0.00248	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—INS—atherosclerosis	0.000256	0.00247	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Lovastatin—atherosclerosis	0.000255	0.00143	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Niacin—atherosclerosis	0.000254	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Rash—Lovastatin—atherosclerosis	0.000253	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Lovastatin—atherosclerosis	0.000253	0.00141	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—CCL2—atherosclerosis	0.000252	0.00244	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Lovastatin—atherosclerosis	0.000251	0.00141	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Ezetimibe—atherosclerosis	0.00025	0.0014	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Pravastatin—atherosclerosis	0.00025	0.0014	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—CRP—atherosclerosis	0.000249	0.00241	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Simvastatin—atherosclerosis	0.000248	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Rash—Ezetimibe—atherosclerosis	0.000248	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Ezetimibe—atherosclerosis	0.000248	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Niacin—atherosclerosis	0.000247	0.00138	CcSEcCtD
Gadobenate Dimeglumine—Headache—Ezetimibe—atherosclerosis	0.000246	0.00138	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Niacin—atherosclerosis	0.000244	0.00136	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Pravastatin—atherosclerosis	0.000243	0.00136	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—APOB—atherosclerosis	0.000242	0.00234	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—APOA1—atherosclerosis	0.000241	0.00233	CbGpPWpGaD
Gadobenate Dimeglumine—Pruritus—Pravastatin—atherosclerosis	0.00024	0.00134	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—F5—atherosclerosis	0.000239	0.00231	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—SELP—atherosclerosis	0.000239	0.00231	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Simvastatin—atherosclerosis	0.000239	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Lovastatin—atherosclerosis	0.000238	0.00133	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—CD36—atherosclerosis	0.000237	0.00229	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Simvastatin—atherosclerosis	0.000237	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Simvastatin—atherosclerosis	0.000236	0.00132	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—SOD2—atherosclerosis	0.000236	0.00228	CbGpPWpGaD
Gadobenate Dimeglumine—Diarrhoea—Niacin—atherosclerosis	0.000236	0.00132	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—SERPINE1—atherosclerosis	0.000235	0.00227	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Simvastatin—atherosclerosis	0.000235	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Ezetimibe—atherosclerosis	0.000234	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Pravastatin—atherosclerosis	0.000232	0.0013	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—PRKCG—atherosclerosis	0.000231	0.00223	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—F2—atherosclerosis	0.00023	0.00222	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—ICAM1—atherosclerosis	0.000229	0.00221	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—CLU—atherosclerosis	0.000228	0.00221	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Niacin—atherosclerosis	0.000228	0.00127	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—CD36—atherosclerosis	0.000226	0.00218	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—GPX1—atherosclerosis	0.000225	0.00218	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Pravastatin—atherosclerosis	0.000224	0.00126	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Simvastatin—atherosclerosis	0.000223	0.00125	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000219	0.00212	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Niacin—atherosclerosis	0.000219	0.00123	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—PDGFB—atherosclerosis	0.000218	0.00211	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Niacin—atherosclerosis	0.000217	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Niacin—atherosclerosis	0.000217	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Headache—Niacin—atherosclerosis	0.000216	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Pravastatin—atherosclerosis	0.000216	0.00121	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—IFNG—atherosclerosis	0.000214	0.00207	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Pravastatin—atherosclerosis	0.000214	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Pravastatin—atherosclerosis	0.000214	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Headache—Pravastatin—atherosclerosis	0.000212	0.00119	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—INS—atherosclerosis	0.000208	0.00201	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—atherosclerosis	0.000208	0.00201	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—MTHFR—atherosclerosis	0.000208	0.00201	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—APOA1—atherosclerosis	0.000207	0.002	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000206	0.00199	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—CCL2—atherosclerosis	0.000205	0.00198	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Niacin—atherosclerosis	0.000205	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Pravastatin—atherosclerosis	0.000201	0.00113	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—CRP—atherosclerosis	0.000198	0.00191	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—atherosclerosis	0.000197	0.0019	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—OLR1—atherosclerosis	0.000196	0.0019	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—APOA1—atherosclerosis	0.000191	0.00185	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—SERPINE1—atherosclerosis	0.000191	0.00185	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—IL1B—atherosclerosis	0.000191	0.00185	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—F2—atherosclerosis	0.000183	0.00177	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—ICAM1—atherosclerosis	0.000182	0.00176	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—VWF—atherosclerosis	0.000181	0.00175	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000179	0.00173	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000179	0.00173	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—NFKB1—atherosclerosis	0.000178	0.00172	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000177	0.00171	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IFNG—atherosclerosis	0.000174	0.00168	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—IGF1—atherosclerosis	0.000173	0.00167	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.00017	0.00164	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—INS—atherosclerosis	0.000165	0.0016	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—atherosclerosis	0.000164	0.00159	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—SERPINE1—atherosclerosis	0.000164	0.00159	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—CCL2—atherosclerosis	0.000163	0.00157	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—atherosclerosis	0.000156	0.00151	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IL1B—atherosclerosis	0.000155	0.0015	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SERPINC1—atherosclerosis	0.000155	0.0015	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—SERPINE1—atherosclerosis	0.000152	0.00147	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—NFKB1—atherosclerosis	0.000145	0.0014	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000141	0.00137	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—TNF—atherosclerosis	0.000139	0.00134	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—IFNG—atherosclerosis	0.000138	0.00134	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—KNG1—atherosclerosis	0.000135	0.00131	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000134	0.0013	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000133	0.00128	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000133	0.00128	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—PTGS2—atherosclerosis	0.000133	0.00128	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PLG—atherosclerosis	0.000131	0.00127	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.00013	0.00126	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—F3—atherosclerosis	0.00013	0.00126	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000128	0.00124	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—SOD1—atherosclerosis	0.000126	0.00121	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—IL1B—atherosclerosis	0.000123	0.00119	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SELP—atherosclerosis	0.000123	0.00119	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—F5—atherosclerosis	0.000123	0.00119	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000122	0.00118	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—IGF2—atherosclerosis	0.000119	0.00115	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000118	0.00114	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CLU—atherosclerosis	0.000118	0.00114	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	0.000116	0.00112	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—NFKB1—atherosclerosis	0.000115	0.00111	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—VEGFA—atherosclerosis	0.000113	0.00109	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—TNF—atherosclerosis	0.000113	0.00109	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000112	0.00109	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000112	0.00109	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000112	0.00109	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000112	0.00109	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—IL6—atherosclerosis	0.000112	0.00108	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000111	0.00107	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—THBD—atherosclerosis	0.000111	0.00107	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000109	0.00106	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PRKCG—atherosclerosis	0.000108	0.00104	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—atherosclerosis	0.000107	0.00104	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000107	0.00104	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000105	0.00102	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—CD36—atherosclerosis	0.000105	0.00102	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SELE—atherosclerosis	0.000105	0.00101	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—TGFB1—atherosclerosis	0.000104	0.001	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000103	0.000992	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	9.88e-05	0.000955	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—atherosclerosis	9.86e-05	0.000954	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—LDLRAP1—atherosclerosis	9.76e-05	0.000944	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PDGFB—atherosclerosis	9.69e-05	0.000937	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	9.54e-05	0.000923	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—VWF—atherosclerosis	9.34e-05	0.000903	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PLTP—atherosclerosis	9.18e-05	0.000888	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—APOA1—atherosclerosis	9.16e-05	0.000886	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IL6—atherosclerosis	9.1e-05	0.00088	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—TNF—atherosclerosis	8.96e-05	0.000866	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—F7—atherosclerosis	8.91e-05	0.000862	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—F2—atherosclerosis	8.74e-05	0.000845	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	8.5e-05	0.000822	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	8.45e-05	0.000817	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	8.4e-05	0.000812	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PIK3CG—atherosclerosis	8.36e-05	0.000809	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	8.2e-05	0.000793	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ABCG8—atherosclerosis	7.96e-05	0.00077	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—LTA4H—atherosclerosis	7.96e-05	0.00077	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PLAT—atherosclerosis	7.94e-05	0.000768	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	7.86e-05	0.00076	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—CETP—atherosclerosis	7.8e-05	0.000754	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—IGF1—atherosclerosis	7.66e-05	0.000741	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	7.42e-05	0.000718	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—SERPINE1—atherosclerosis	7.27e-05	0.000703	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—IL6—atherosclerosis	7.23e-05	0.000699	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—KNG1—atherosclerosis	6.97e-05	0.000674	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PLAUR—atherosclerosis	6.91e-05	0.000668	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—PLAT—atherosclerosis	6.87e-05	0.000665	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PLG—atherosclerosis	6.75e-05	0.000653	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	6.61e-05	0.00064	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SOD1—atherosclerosis	6.47e-05	0.000626	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ABCG1—atherosclerosis	6.29e-05	0.000608	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—IGF2—atherosclerosis	6.15e-05	0.000595	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—APOB—atherosclerosis	5.97e-05	0.000577	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—FABP4—atherosclerosis	5.91e-05	0.000572	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—LCAT—atherosclerosis	5.91e-05	0.000572	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—PLG—atherosclerosis	5.85e-05	0.000565	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOA4—atherosclerosis	5.8e-05	0.000561	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP7A1—atherosclerosis	5.7e-05	0.000551	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PRKCG—atherosclerosis	5.54e-05	0.000536	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	5.43e-05	0.000526	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CD36—atherosclerosis	5.42e-05	0.000524	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.39e-05	0.000522	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP27A1—atherosclerosis	5.27e-05	0.00051	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	5.19e-05	0.000502	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—APOB—atherosclerosis	5.17e-05	0.0005	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	5.06e-05	0.00049	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	5e-05	0.000484	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ALOX5AP—atherosclerosis	5e-05	0.000483	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ALOX15—atherosclerosis	5e-05	0.000483	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PLA2G2A—atherosclerosis	5e-05	0.000483	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOA2—atherosclerosis	5e-05	0.000483	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PDGFB—atherosclerosis	4.99e-05	0.000483	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—MMP1—atherosclerosis	4.94e-05	0.000477	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ABCG5—atherosclerosis	4.94e-05	0.000477	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	4.93e-05	0.000477	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—LPA—atherosclerosis	4.77e-05	0.000461	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CAV1—atherosclerosis	4.73e-05	0.000458	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	4.73e-05	0.000458	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—APOA1—atherosclerosis	4.72e-05	0.000457	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—BGN—atherosclerosis	4.62e-05	0.000446	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	4.59e-05	0.000444	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	4.58e-05	0.000443	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOA5—atherosclerosis	4.57e-05	0.000442	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—F2—atherosclerosis	4.51e-05	0.000436	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—NOS2—atherosclerosis	4.45e-05	0.000431	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.44e-05	0.000429	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PLA2G1B—atherosclerosis	4.4e-05	0.000425	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.36e-05	0.000421	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.35e-05	0.000421	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PIK3CG—atherosclerosis	4.31e-05	0.000417	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.31e-05	0.000417	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.3e-05	0.000416	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ALOX5—atherosclerosis	4.25e-05	0.000411	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.09e-05	0.000395	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—IGF1—atherosclerosis	3.95e-05	0.000382	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.93e-05	0.00038	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NAMPT—atherosclerosis	3.81e-05	0.000369	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.79e-05	0.000366	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—LIPC—atherosclerosis	3.79e-05	0.000366	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOC3—atherosclerosis	3.76e-05	0.000364	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SERPINE1—atherosclerosis	3.75e-05	0.000363	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—LDLR—atherosclerosis	3.74e-05	0.000362	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CETP—atherosclerosis	3.65e-05	0.000353	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—NOS3—atherosclerosis	3.58e-05	0.000346	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SCARB1—atherosclerosis	3.5e-05	0.000338	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HMGCR—atherosclerosis	3.3e-05	0.00032	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	3.19e-05	0.000309	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.98e-05	0.000288	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ABCA1—atherosclerosis	2.94e-05	0.000285	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—VEGFA—atherosclerosis	2.58e-05	0.000249	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HMOX1—atherosclerosis	2.53e-05	0.000244	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—MAPK3—atherosclerosis	2.44e-05	0.000236	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOB—atherosclerosis	2.42e-05	0.000234	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—TGFB1—atherosclerosis	2.37e-05	0.000229	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTM1—atherosclerosis	2.35e-05	0.000228	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—LPL—atherosclerosis	2.31e-05	0.000223	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GPX1—atherosclerosis	2.25e-05	0.000218	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CD36—atherosclerosis	2.2e-05	0.000212	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—MTHFR—atherosclerosis	2.08e-05	0.000201	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PPARA—atherosclerosis	2.04e-05	0.000197	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AGT—atherosclerosis	1.98e-05	0.000191	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOE—atherosclerosis	1.94e-05	0.000187	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CAV1—atherosclerosis	1.92e-05	0.000186	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOA1—atherosclerosis	1.91e-05	0.000185	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PIK3CG—atherosclerosis	1.75e-05	0.000169	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PPARG—atherosclerosis	1.69e-05	0.000163	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—INS—atherosclerosis	1.65e-05	0.00016	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—AKT1—atherosclerosis	1.65e-05	0.000159	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NOS3—atherosclerosis	1.45e-05	0.00014	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PTGS2—atherosclerosis	1.33e-05	0.000128	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AKT1—atherosclerosis	6.67e-06	6.45e-05	CbGpPWpGaD
